Literature DB >> 12044938

In memoriam Bernard Strehler--genomic instability in ageing: a persistent challenge.

Alexander Bürkle1.   

Abstract

Genomic instability comprises a broad spectrum of mutational alterations in the genome, such as point mutations in DNA, microsatellite expansions or contractions, amplifications and deletions of DNA sequences, gene rearrangements and structural or numerical chromosomal aberrations. A substantial body of data demonstrates an increase of genomic instability during normal ageing. This includes cytogenetic changes; loss of rDNA; formation of extrachromosomal circular DNA species; loss of telomeric repeats; increased microsatellite instability; as well as point mutations and deletions in global nuclear and mitochondrial DNA. Evidence has accumulated supporting a causative role of genomic instability in ageing. Genomic instability can be counteracted by a number of proteins including antioxidant enzymes, the WRN protein (deficient in Werner syndrome), telomerase, poly(ADP-ribose) polymerase-1 and a range other others, as well as by multi-protein systems such as DNA mismatch repair, base-excision repair and nucleotide-excision repair. Important research tasks for the future will be to elucidate how and what extent the various expressions of genomic instability contribute to the ageing process and to understand the molecular mechanisms and regulation of the above factors and pathways involved in limiting the induction of ageing-associated genomic instability.

Entities:  

Mesh:

Year:  2002        PMID: 12044938     DOI: 10.1016/s0047-6374(02)00027-1

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  1 in total

1.  Variation in ribosomal DNA copy number is associated with lung cancer risk in a prospective cohort study.

Authors:  H Dean Hosgood; Wei Hu; Nathaniel Rothman; Madelyn Klugman; Stephanie J Weinstein; Jarmo R Virtamo; Demetrius Albanes; Richard Cawthon; Qing Lan
Journal:  Carcinogenesis       Date:  2019-08-22       Impact factor: 4.944

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.